HotHouse Therapeutics

United Kingdom - Norwich, Norfolk

• 03/12/2025
• Pre-Seed
• $3,835,279

HotHouse Therapeutics is rewriting the future of drug discovery with BotanAI and BotanBio - our AI and plant bioengineering platforms that design and make molecules labs can’t reach.

By transforming plants into sustainable biofactories, we unlock vast new chemical space, creating next-generation vaccine adjuvants and breakthrough therapeutics in days, not years.

The urgency is clear: 62% of today’s medicines are natural or nature-inspired, yet conventional chemistry is slow, expensive, and environmentally harmful. As a sustainable biotech, our approach is different. Because our medicines grow in plants, they scale through vertical farming, are carbon-positive by design, and avoid destructive extraction.

With deep expertise in plant science, chemistry, and AI, we’re building not just a pipeline, but a platform - delivering next-generation medicines that are greener, faster, and smarter.

Related People

David SheppardFounder

United Kingdom - Cambridge, England

Biotech entrepreneur, innovator, leader and consultant. Pioneer of Targeted Protein Stabilisation, Founder of EntactBio and Board member of RevoNA Bio. Experienced, enthusiastic and entrepreneurial pharmaceuticals professional, a proven track record of scientific excellence and a passion for disruptive innovation through new technology platforms and start-ups.

LinkedIn https://www.linkedin.com/in/david-sheppard/